191 related articles for article (PubMed ID: 29414429)
1. Characteristics, survival and incidence rates and trends of primary cardiac malignancies in the United States.
Saad AM; Abushouk AI; Al-Husseini MJ; Salahia S; Alrefai A; Afifi AM; Abdel-Daim MM
Cardiovasc Pathol; 2018; 33():27-31. PubMed ID: 29414429
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and Survival of Malignant Cardiac Tumors: A 40-Year Analysis of >500 Patients.
Oliveira GH; Al-Kindi SG; Hoimes C; Park SJ
Circulation; 2015 Dec; 132(25):2395-402. PubMed ID: 26467256
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
4. Nomograms and risk classification systems predicting overall and cancer-specific survival in primary malignant cardiac tumor.
Guan T; Li Y; Qiu Z; Zhang Y; Lin W; Lai Y; Wang K; Shen Y; Du L; Liu C
J Card Surg; 2019 Dec; 34(12):1540-1549. PubMed ID: 31794125
[TBL] [Abstract][Full Text] [Related]
5. Survival Differences in Men and Women With Primary Malignant Cardiac Tumor: An Analysis Using the Surveillance, Epidemiology and End Results (SEER) Database From 1973 to 2015.
Antwi-Amoabeng D; Meghji Z; Thakkar S; Ulanja MB; Taha M; Adalja D; Al-Khafaji J; Gullapalli N; Beutler BD; Boampong-Konam K; Doshi R
J Am Heart Assoc; 2020 May; 9(10):e014846. PubMed ID: 32389047
[TBL] [Abstract][Full Text] [Related]
6. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
7. The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.
Xiao M; Lin J; Xiao T; Lin Y; Ye Y
Hematol Oncol; 2020 Aug; 38(3):334-343. PubMed ID: 32311106
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases.
Lee KC; Chuang SK; Philipone EM; Peters SM
Head Neck Pathol; 2019 Sep; 13(3):378-385. PubMed ID: 30357539
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin's lymphoma.
Greiner TC; Medeiros LJ; Jaffe ES
Cancer; 1995 Jan; 75(1 Suppl):370-80. PubMed ID: 8001008
[TBL] [Abstract][Full Text] [Related]
10. Sphenoid sinus malignancies: a population-based comprehensive analysis.
Ghosh R; Dubal PM; Chin OY; Patel TD; Echanique KA; Baredes S; Liu JK; Eloy JA
Int Forum Allergy Rhinol; 2016 Jul; 6(7):752-9. PubMed ID: 26891865
[TBL] [Abstract][Full Text] [Related]
11. Primary Cardiac Sarcoma: 25-Year Cleveland Clinic Experience.
Randhawa JS; Budd GT; Randhawa M; Ahluwalia M; Jia X; Daw H; Spiro T; Haddad A
Am J Clin Oncol; 2016 Dec; 39(6):593-599. PubMed ID: 25036471
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Nasopharyngeal Lymphoma in the United States: A Population-Based Analysis of 1119 Cases.
Han AY; Kuan EC; Alonso JE; Badran KW; St John MA
Otolaryngol Head Neck Surg; 2017 May; 156(5):870-876. PubMed ID: 28322119
[TBL] [Abstract][Full Text] [Related]
13. Changing incidence of non-Hodgkin lymphomas in the United States.
Clarke CA; Glaser SL
Cancer; 2002 Apr; 94(7):2015-23. PubMed ID: 11932904
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, tumor characteristics and survival in patients with angiosarcoma in the United States: a population-based study of 4537 cases.
Zhang C; Xu G; Liu Z; Xu Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Mao M; Wang X; Wang G; Zhang C
Jpn J Clin Oncol; 2019 Dec; 49(12):1092-1099. PubMed ID: 31612920
[TBL] [Abstract][Full Text] [Related]
15. Incidence, prognostic significance, and survival outcomes of primary cardiac sarcoma: An updated population-based retrospective study.
Hammami MB; Al-Wawi MZ; Fazel H; Oudih M
Anatol J Cardiol; 2021 Feb; 25(2):104-110. PubMed ID: 33583817
[TBL] [Abstract][Full Text] [Related]
16. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
17. Survival predictors of metastatic angiosarcomas: a surveillance, epidemiology, and end results program population-based retrospective study.
Ren S; Wang Y; Wang Z; Shao J; Ye Z
BMC Cancer; 2020 Aug; 20(1):778. PubMed ID: 32811474
[TBL] [Abstract][Full Text] [Related]
18. The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity.
Chandrasekar T; Goldberg H; Klaassen Z; Wallis CJD; Woon DTS; Herrera-Caceres JO; Kulkarni GS; Fleshner NE
Cancer; 2019 Apr; 125(7):1050-1059. PubMed ID: 30561782
[TBL] [Abstract][Full Text] [Related]
19. Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013.
Khanna V; Achey RL; Ostrom QT; Block-Beach H; Kruchko C; Barnholtz-Sloan JS; de Blank PM
J Neurooncol; 2017 Dec; 135(3):433-441. PubMed ID: 28828582
[TBL] [Abstract][Full Text] [Related]
20. Cardiac non-Hodgkin's lymphoma: clinical characteristics and trends in survival.
Gordon MJ; Danilova O; Spurgeon S; Danilov AV
Eur J Haematol; 2016 Nov; 97(5):445-452. PubMed ID: 26935129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
